Search results
6 lut 2024 · Comprehensive genomic profiling (CGP) is ushering in an era of precision medicine by making it easier to treat tumors in a targeted manner. Check out 10 leading specialists providing these game-changing services.
24 lip 2021 · A number of genetic testing companies now offer whole genome sequencing by leveraging NGS technology (usually from Illumina) either directly to consumers or through healthcare providers. These tests provide a deep dive into a patient’s genetics.
14 cze 2019 · The 2 broad molecular profiling next-generation sequencing tests approved by the FDA that interrogate the most number of genes at once are the the FoundationOne CDx (F1CDx) test and the...
Our tumor genomic tests can find common genetic mutations linked to cancer. These include changes in the genes EGFR, KRAS, BRAF, and PIK3CA. Our tests can also find less common cancer mutations, such as changes in the genes NTRK, ROS1, and ALK.
Genetic testing for cancer-related disorders has significantly improved in accuracy and affordability, potentially revolutionizing monitoring and treatment methods. The expanding knowledge of genetic mutations associated with cancer susceptibility has driven significant progress in cancer therapy.
Genetic testing allows patients and their providers to better understand certain cancers, so they know how to best treat them. By unlocking targeted therapies, advanced treatment options and clinical trials, genetic information can help create clarity amid the complexity of cancer treatment decisions.
7 cze 2023 · We performed a comprehensive literature review to identify recent English language publications that presented progression-free survival (PFS) and overall survival (OS) of patients with advanced cancer receiving NGS testing.
